Zou et al. [21] reported that patients with lung adenocarcinoma with lower HEG1 mRNA expression tended to have a worse prognosis, advanced stage, and high malignancy, indicating that HEG1 has prognostic significance at the clinical level. The gene discussed is HEG1; the disease is lung adenocarcinoma.